Úc - Tiếng Anh - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - refer to label - oral powder, pre-mix - refer to label misc active 0.0 undefined - musculoskeletal system - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - improve joint function

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

hope pharmaceuticals pty ltd - sodium thiosulfate pentahydrate, quantity: 12.5 g - solution - excipient ingredients: water for injections; potassium chloride; boric acid; sodium hydroxide - hope pharmaceuticals sodium thiosulfate injection is indicated as an antidote in the treatment of cyanide poisoning. it is frequently used in conjunction with sodium nitrite.,sodium thiosulfate is also indicated to prevent sodium nitroprusside induced cyanide poisoning.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd t/a depuy synthes - 61781 - joint prosthesis implantation kit, single-use - a collection of sterile, single use, surgical instruments intended to be used for cutting and forming bone to enable the implantation of a joint prosthesis.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dexmedetomidine hydrochloride, quantity: 4.72 microgram/ml (equivalent: dexmedetomidine, qty 4 microgram/ml) - injection, intravenous infusion - excipient ingredients: sodium chloride; water for injections - intensive care unit (icu) sedation: for sedation of initially intubated adult patients during treatment in an intensive care setting. the use of precedex ready to use by continuous infusion in these patients should not exceed 24 hours.,procedural sedation: for sedation of non-intubated adult patients prior to and/or during surgical and other procedures.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

cerner corporation pty ltd - 58842 - pharmaceutical information system application software - an application , routine, and/or algorithm intended for use as or in an information system to receive, collect, store, manage,assist in analysis of, display, output and distribute data within or between healthcare facilities, to assist with therapeutic pharmaceutical prescription and management

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: sodium hydroxide; phosphoric acid; water for injections; alpha lipoic acid; glycocholic acid; sodium chloride; meglumine - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the,reduction of fever where an intravenous route of administration is considered clinically necessary.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; meglumine; glycocholic acid; sodium hydroxide; phosphoric acid; sodium chloride; alpha lipoic acid - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the,reduction of fever where an intravenous route of administration is considered clinically necessary.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: phosphoric acid; meglumine; alpha lipoic acid; glycocholic acid; sodium hydroxide; water for injections; sodium chloride - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the,reduction of fever where an intravenous route of administration is considered clinically necessary.